Roche said it has removed its thrombolytic drug tenecteplase from phase 3 for for acute ischaemic stroke, along with several earlier-stage projects. The fibrin-specific plasminogen activator ...

In recent years, the number of major drug recalls within the Pharmaceutical industry has skyrocketed from 426 in 2008 to 1,742 in 2009 according to CNNMoney. 1 Even more alarming is the increase ...